Stock BTPC ACTIVE BIOTECH AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Active Biotech AB Xetra

Equities

BTPC

SE0001137985

End-of-day quote Xetra
Other stock markets
- EUR - Intraday chart for Active Biotech AB
05-22 Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug MT
05-22 Active Biotech Enters into an Exclusive License Agreement with the Wistar Institute of Anatomy and Biology CI

Press Releases

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Number of shares and votes in Active Biotech
AQ
Clinical activity and safety of naptumomab and docetaxel to be presented at ASCO 2024
AQ
Annual General Meeting of Active Biotech AB
AQ
Active Biotech acquires exclusive rights to patents of tasquinimod in combination therapy
AQ
Active Biotech : Interview with Prof. Dr. Axel Glasmacher, Independent Board Member at Active Biotech
PU
Active Biotech Q1 2024 - Approching Naptumomab Topline Data in Lung Cancer
AQ
Active Biotech Interim Report Q1 2024
AQ
Annual Report 2023 Active Biotech AB (publ)
AQ
Active Biotech announces start of enrollment to the clinical phase I biodistribution study with laquinimod eye drops
AQ
Active Biotech Q4 2023 - Three Externally Funded Trials in 2024
AQ
Active Biotech Year End Report 2023
AQ
Number of shares and votes in Active Biotech
AQ
Active Biotech provides update on the scheduled clinical program for 2024
AQ
Positive preclinical tasquinimod data presented at ASH 2023 now available on Active Biotech’s website
AQ
Active Biotech announces outcome of the Company’s rights issue
AQ
Active Biotech enters into collaboration agreement for clinical ocular biodistribution study with laquinimod
AQ
Active Biotech's nomination committee appointed
AQ
Lead Principal Investigator Rebekka Schneider-Kramann presents the clinical plan and positioning of tasquinimod in myelofibrosis
AQ
Management and members of the board of directors have subscribed for shares in Active Biotech’s ongoing rights issue
AQ
Active Biotech publishes prospectus
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACTI Stock
  4. BTPC Stock
  5. News Active Biotech AB
  6. Press Releases
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW